Related Experiment Videos

Anti-idiotype antibodies as potential therapeutic agents for human breast cancer

M Bhattacharya-Chatterjee¹, E Mrozek, S Mukerjee

¹Department of Lucille Markey Cancer Center, University of Kentucky College of Medicine, Lexington 40536.

Advances in Experimental Medicine and Biology

|January 1, 1994

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Breast cancer and aging: results of the U13 conference breast cancer panel.

Breast cancer research and treatment·2014

Der(16)T(1-16) is a nonrandom secondary chromosome aberration in many types of human neoplasia, including myxoid liposarcoma, rhabdomyosarcoma and Philadelphia-chromosome-positive acute lymphoblastic-leukemia.

International journal of oncology·2011

Phase II study of sequentially administered low-dose mitomycin-C (MMC) and irinotecan (CPT-11) in women with metastatic breast cancer (MBC).

Annals of oncology : official journal of the European Society for Medical Oncology·2008

Phase I trial of liposomal encapsulated doxorubicin (Myocet; D-99) and weekly docetaxel in advanced breast cancer patients.

Annals of oncology : official journal of the European Society for Medical Oncology·2005

Radiation-free regimens result in similar outcomes of allogeneic hematopoietic progenitor cell transplantation in patients aged >or=50 years compared to younger adults with low-risk disease.

Bone marrow transplantation·2003

Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy.

The Journal of clinical investigation·2000

See all related articles